The Gastric Bypass Stent System as a Treatment for Hepatic Fibrosis in Obese Patients in European Region

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 13, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
FibrosisLiver
Interventions
DEVICE

Gastric Bypass Stent System

The Gastric Bypass Stent System is intended to be used in weight loss treatment for obesity holds potential as a non-invasive technique for managing hepatic fibrosis. This clinical investigation will be used to evaluate the safety and performance of the investigational device for the intended use.

Trial Locations (2)

LV1013

RECRUITING

"REUH, hospital lnfectology center of Latvia", Riga

LV-1079

RECRUITING

"Digestive Diseases Centre GASTRO", Riga

All Listed Sponsors
collaborator

Hangzhou Tangji Medical Technology Co., Ltd.

OTHER

lead

MDCECRO LLC

NETWORK